ACC/AHA 2007 Atrial Fibrillation Management Guidelines Source: ACC/AHA 2007 Pocket Guide
Patterns of Atrial Fibrillation
Medical Management of Patients With Newly Discovered AFib
Medical Management of Patients with Recurrent Paroxysmal AFib
Medical Management of Patients With Recurrent Persistent or Permanent AFib
Medical Management to Maintain Sinus Rhythm in Patients With Recurrent Paroxysmal or Persistent Atrial Fibrillation
Recommendations for Pharmacological Cardioversion of Atrial Fibrillation of Up To 7 Days Duration
Recommendations for Pharmacological Cardioversion of Atrial Fibrillation Present for More Than 7 Days Duration
Recommended Doses of Drugs Proven Effective for Pharmacological Cardioversion of Atrial Fibrillation
Pharmacological Rx Before Cardioversion in Patients With Persistent AF: Effects of Various Antiarrhythmic Drugs on Immediate Recurrence, Outcome of Transthoracic Direct-Current Shock, or Both
Typical Doses of Drugs Used to Maintain Sinus Rhythm in Patients with Atrial Fibrillation
I.V. and Oral Medications to Establish Heart Rate Control in Patients With Atrial Fibrillation
I.V. and Oral Pharmacological Agents to Maintain Heart Rate Control in Atrial Fibrillation
Stroke Risk in Patients With Non-Valvular AF, If No Anticoagulant Given - CHADS2 Index
Anti-thrombotic Therapy for Patients With Atrial Fibrillation